ICTO 2026 – Distinguished Keynote Presentation

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to welcome Jianhua Luo from the University of Pittsburgh School of Medicine, United States, as a distinguished Keynote Presenter at the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group.

As part of the scientific program, Jianhua Luo will deliver an insightful keynote presentation titled:

“Fusion genes detection enhances clinical outcome prediction of hepatocellular carcinoma through machine learning analyses”

The presentation will highlight emerging approaches in hepatocellular carcinoma, focusing on the potential of fusion gene detection and machine learning analyses to enhance clinical outcome prediction and support advances in cancer research.

ICTO 2026 brings together researchers, clinicians, healthcare professionals, academics, and industry experts from around the world to exchange knowledge, discuss emerging developments, present innovative research, and explore new opportunities in clinical and translational oncology.

The conference provides an international platform to engage with experts, discover advances in cancer research and care, and foster meaningful scientific and professional collaborations.

📌 Keynote Presenter: Jianhua Luo
🏛️ Affiliation: University of Pittsburgh School of Medicine, United States
🎤 Presentation: Fusion genes detection enhances clinical outcome prediction of hepatocellular carcinoma through machine learning analyses

📅 Conference Dates: October 8–10, 2026
📍 Location: Tokyo, Japan
🌐 Format: Hybrid Event

Join ICTO 2026 and be part of an international scientific gathering advancing the future of clinical and translational oncology.

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

🔗 More Information: https://magnusconferences.com/cancer-oncology/

#ICTO2026 #KeynoteSpeaker #ClinicalOncology #TranslationalOncology #CancerResearch #HepatocellularCarcinoma #MachineLearning #OncologyConference #PrecisionOncology #CancerCare #MedicalResearch

🌟 Why Wait? Register Early for ICTO 2026!

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to announce the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place October 8–10, 2026, in Tokyo, Japan and Online as a Hybrid Event.

ICTO 2026 provides an excellent platform for researchers, clinicians, healthcare professionals, academics, and industry experts to present their latest research, share innovative findings, discuss emerging developments, and connect with the global oncology community.

Make the most of your participation at ICTO 2026 – 9th Edition of the International Conference on Clinical & Translational Oncology.

🎟️ Catch the Early Bird Advantage!

• Save with Early Bird registration rates
• Connect with global oncology experts
• Discover the latest advances in cancer research
• Participate in scientific sessions and discussions
• Expand your professional network

📅 October 8–10, 2026
📍 Tokyo, Japan
🌐 Hybrid Event

⏳ Don’t miss the Early Bird opportunity! Register early and save more.

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

🔗 More Information: https://magnusconferences.com/cancer-oncology/

Join ICTO 2026 and connect with the global oncology community.

#ICTO2026 #EarlyBirdRegistration #OncologyConference #ClinicalOncology #TranslationalOncology #CancerResearch #TokyoJapan

⏰ Early Bird Registrations Are Closing Soon!

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

⏰ Early Bird Registrations Are Closing Soon!

We are pleased to invite you to the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place October 8–10, 2026, in Tokyo, Japan and Online as a Hybrid Event.

Early Bird Registrations are closing soon, providing participants with an opportunity to register early and benefit from the special early registration rates.

ICTO 2026 brings together researchers, clinicians, healthcare professionals, academics, scientists, and industry experts from around the world to present their latest research, share innovative findings, discuss emerging developments, and connect with the global oncology community.

Professionals and researchers working in clinical oncology, translational oncology, cancer research, cancer care, precision medicine, medical research, and related fields are invited to participate in this international scientific gathering.

The conference offers an excellent opportunity to exchange knowledge, explore emerging developments in oncology, present research, build professional connections, and engage with experts from around the world.

📅 Conference Dates: October 8–10, 2026
📍 Location: Tokyo, Japan
🌐 Format: Hybrid Event

⏰ Early Bird Registrations Are Closing Soon – Register Now!

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

🔗 More Information: https://magnusconferences.com/cancer-oncology/

Join ICTO 2026 and be part of the global oncology community.

🎟️ Register early and save more!

👉 Visit the ICTO 2026 Official Website

#ICTO2026 #ClinicalOncology #TranslationalOncology #CancerResearch #OncologyConference #CancerCare #PrecisionMedicine #MedicalResearch #EarlyBirdRegistration #OncologyConference2026 #HybridConference #TokyoConference

ICTO 2026 – 9th Edition of the International Conference on Clinical & Translational Oncology

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to announce the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place October 8–10, 2026, in Tokyo, Japan and Online as a Hybrid Event.

ICTO 2026 provides an excellent platform for researchers, clinicians, healthcare professionals, academics, and industry experts to present their latest research, share innovative findings, discuss emerging developments, and connect with the global oncology community.

Researchers and professionals working in clinical oncology, translational oncology, cancer research, cancer care, precision medicine, medical research, and related fields are invited to submit their abstracts and contribute to this international scientific gathering.

The conference offers an opportunity to exchange knowledge, explore emerging developments in oncology, build professional connections, and engage with experts from around the world.

📅 Conference Dates: October 8–10, 2026
📍 Location: Tokyo, Japan
🌐 Format: Hybrid Event

Join ICTO 2026 and be part of the global oncology community.

🎟️ Register early and save more!

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

🔗 More Information: https://magnusconferences.com/cancer-oncology/

#ICTO2026 #ClinicalOncology #TranslationalOncology #CancerResearch #OncologyConference #CancerCare #PrecisionMedicine #MedicalResearch

⏳ 1st Round of Abstract Submission Closes Soon! – ICTO 2026!

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

We are pleased to announce the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group, taking place October 8–10, 2026, in Tokyo, Japan and Online as a Hybrid Event.

ICTO 2026 provides an excellent platform for researchers, clinicians, healthcare professionals, academics, and industry experts to present their latest research, share innovative findings, discuss emerging developments, and connect with the global oncology community.

Researchers and professionals working in clinical oncology, translational oncology, cancer research, cancer care, precision medicine, medical research, and related fields are invited to submit their abstracts and contribute to this international scientific gathering.

🔗 Learn more about ICTO 2026:

https://magnusconferences.com/cancer-oncology/

📝 Submit your Abstract:

https://magnusconferences.com/cancer-oncology/submit-abstract

👉 Register for ICTO 2026:

https://magnusconferences.com/cancer-oncology/register

📞 Phone: +1 (702) 988-2320

📱 WhatsApp: +1 (640) 666 9566

📧 Email: cancer@magnusconferences.com

🌟 Join ICTO 2026 and share your research with the global clinical and translational oncology community!

#ICTO2026 #Oncology #CancerResearch #ClinicalOncology #TranslationalOncology #CancerCare #MedicalResearch #CancerConference #AbstractSubmission #TokyoJapan #Healthcare #ResearchConference

Call for Papers: 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026)

 The 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) is scheduled to take place on October 8–10, 2026, in Tokyo, Japan, as a hybrid event offering both in-person and virtual participation organized by Magnus Group.

The conference brings together researchers, clinicians, healthcare professionals, academicians, scientists, and industry experts to exchange knowledge, present innovative research, and discuss emerging developments in clinical and translational oncology.

Why Participate?

ICTO 2026 provides an international platform to:

• Present original research and recent scientific findings
• Exchange knowledge with oncology professionals and researchers
• Discuss emerging advances in clinical and translational oncology
• Build international academic and professional collaborations
• Explore developments that can help bridge laboratory research and clinical applications

📄 Call for Papers

Researchers and professionals are invited to submit their papers and research contributions for consideration at the conference.

Conference: 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026)
Dates: October 8–10, 2026
Location: Tokyo, Japan
Format: Hybrid Event

For conference information and paper submission details, visit: https://magnusconferences.com/cancer-oncology/

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

Join ICTO 2026 and be part of an international scientific platform dedicated to advancing clinical and translational oncology.

#ICTO2026 #ClinicalOncology #TranslationalOncology #CancerResearch #OncologyConference #CancerResearch2026 #CallForPapers #MedicalResearch #TokyoJapan #HealthcareInnovation #MagnusConferences

Keynote Speaker Yan Leyfman to Discuss Large Language Models in Oncology at ICTO 2026

 📅 October 8–10, 2026 | 📍 Tokyo, Japan | 🌐 Hybrid Event

🌟 We are delighted to announce Yan Leyfman from NYP – Meyer Cancer Center, United States, as a Keynote Speaker at the 9th Edition of International Conference on Clinical & Translational Oncology (ICTO 2026), hosted by Magnus Group.

Yan Leyfman will deliver a keynote presentation titled:

🎤 “Real-world clinician adoption and disease-specific safety failures of large language models in oncology clinical decision support.”

The presentation will explore an important area at the intersection of large language models, artificial intelligence, clinical decision support, and oncology, focusing on real-world clinician adoption and disease-specific safety considerations.

🔗 Learn more about the 9th Edition of International Conference on Clinical & Translational Oncology (ICTO 2026): https://magnusconferences.com/cancer-oncology/

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

👉 Register for ICTO 2026: https://magnusconferences.com/cancer-oncology/register

📞 Phone: +1 (702) 988-2320
📱 WhatsApp: +1 (640) 666 9566
📧 Email: cancer@magnusconferences.com

For more updates, follow our ICTO 2026 Blog.

#ICTO2026 #YanLeyfman #Oncology #CancerResearch #ClinicalOncology #TranslationalOncology #ArtificialIntelligence #LargeLanguageModels #LLM #ClinicalDecisionSupport #HealthcareAI